Argus Research analyst David Toung maintains Cardinal Health (NYSE:CAH) with a Buy and lowers the price target from $120 to $115.
Argus Research Maintains Buy on Cardinal Health, Lowers Price Target to $115
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.